Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Group A streptococcus.

Judith M Martin1, Michael Green

  • 1Department of Pediatrics, University of Pittsburgh School of Medicine, Division of Infectious Diseases, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, USA. Judy.martin@chp.edu

Seminars in Pediatric Infectious Diseases
|August 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and immunogenicity of 4CMenB and MenACWY-CRM meningococcal vaccines when administered concomitantly in healthy adolescents: A phase 3b, randomized, observer-blind study.

Human vaccines & immunotherapeutics·2026
Same author

Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants.

JAMA network open·2026
Same author

Comparison of influenza hemagglutination inhibition titers from capillary blood versus venipuncture.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2026
Same author

Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial.

Pediatrics·2026
Same author

The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost.

Science translational medicine·2026
Same author

Overview of 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment using clinical scoring systems in children and adults.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Editorial.

Seminars in pediatric infectious diseases·2020
Same journal

Viral pharyngitis.

Seminars in pediatric infectious diseases·2020
Same journal

The epidemiology of respiratory infections in children.

Seminars in pediatric infectious diseases·2020
Same journal

Antiviral agents in the critically ill child.

Seminars in pediatric infectious diseases·2020
Same journal

Serious and lethal respiratory tract infections of viral etiology in children.

Seminars in pediatric infectious diseases·2020
Same journal

Subject index.

Seminars in pediatric infectious diseases·2020
See all related articles

Group A streptococci (GAS) cause various infections by inhibiting phagocytosis with M proteins. Vaccine development is underway but still in early stages.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Group A streptococci (GAS), or Streptococcus pyogenes, are Gram-positive cocci identified by M protein serotypes.
  • M proteins on the GAS cell surface are key virulence factors, inhibiting phagocytosis.
  • GAS colonizes the pharynx and skin, leading to diverse clinical manifestations.

Purpose of the Study:

  • To review the spectrum of infections caused by GAS.
  • To discuss both suppurative and nonsuppurative complications of GAS infections.
  • To highlight the importance of GAS in pediatric infections and current vaccine research.

Main Methods:

  • Literature review of GAS infections and complications.
  • Analysis of GAS virulence factors, particularly M proteins.

Related Experiment Videos

  • Overview of current vaccine development status.

    • Main Results:

    • GAS infections range from pharyngitis and skin infections to invasive diseases like toxic shock syndrome and necrotizing fasciitis.
    • Nonsuppurative sequelae include acute rheumatic fever and post-streptococcal glomerulonephritis.
    • GAS remains a significant cause of pediatric infections in various healthcare settings.

    Conclusions:

    • GAS infections present a broad clinical spectrum, necessitating comprehensive understanding.
    • Effective vaccines against GAS are needed but are currently in preliminary development.
    • Continued research into GAS pathogenesis and prevention is crucial.